Together, the findings suggest the hypothesis that genetic variants at SLCO1B3 (and/or SLCO1B1) increase the risk of clozapine-associated neutropenia through a pharmacokinetic mechanism. This evidence concerns the gene SLCO1B3 and Decreased total neutrophil count.